NIH-funded research R01 grant

Interrupting harmful lung cell interactions to reduce fluid leakage in critically ill children with bronchiolitis

Official title: Interrupting pro-inflammatory pulmonary-vascular cell interactions to reduce pulmonary capillary leak in critically ill children with bronchiolitis

Funded at Yale University · NIH-11401847 · Data updated 2026-11-12

AYA pediatric patients with bronchiolitis who are severely ill may benefit from a study that targets lung cell signals to lessen fluid leak and improve breathing.

More Critically Ill research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startSeptember 1, 2025
Project endMay 31, 2029
Funding year2026
Award (this year)$879,183
NIH project number5R01HL176019-02
Project IDNIH-11401847 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are children under 2 years old with bronchiolitis who are admitted to the hospital and may require respiratory support.

Less likely to help

Very mild bronchiolitis cases not requiring hospitalization may not directly benefit from this study.

What this research studies

This study focuses on very young children with bronchiolitis who need intensive care. Researchers will look at how signals from lung cells trigger inflammation and leakiness in the tiny blood vessels, contributing to lung dysfunction. Using human samples and animal models, they aim to map these interactions and identify markers that predict severity. The goal is to find therapies that reduce capillary leak and help children recover better. The work builds on prior data from single-cell analyses of lung tissue and airway samples.

Why it matters

Potential benefit: If successful, this work could lead to new treatments that reduce lung fluid buildup and improve outcomes for severely ill infants and young children with bronchiolitis.

How similar studies have gone: Prior studies using IL-1 signaling and alveolar-endothelial interactions have shown promise in animal and human samples, supporting this approach.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Pierce, Richard W — Yale University
  • Study coordinator: Pierce, Richard W

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.